WO2000041671A3 - Composition, device, and method for subcutaneous fat removal - Google Patents

Composition, device, and method for subcutaneous fat removal Download PDF

Info

Publication number
WO2000041671A3
WO2000041671A3 PCT/US1999/029374 US9929374W WO0041671A3 WO 2000041671 A3 WO2000041671 A3 WO 2000041671A3 US 9929374 W US9929374 W US 9929374W WO 0041671 A3 WO0041671 A3 WO 0041671A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
subcutaneous fat
fat removal
skin
topical application
Prior art date
Application number
PCT/US1999/029374
Other languages
French (fr)
Other versions
WO2000041671A2 (en
WO2000041671A9 (en
Inventor
Nikolai Tankovich
Original Assignee
T & T Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T & T Pharmaceuticals Ltd filed Critical T & T Pharmaceuticals Ltd
Publication of WO2000041671A2 publication Critical patent/WO2000041671A2/en
Publication of WO2000041671A3 publication Critical patent/WO2000041671A3/en
Publication of WO2000041671A9 publication Critical patent/WO2000041671A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/89—Suction aspects of liposuction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84—Drainage tubes; Aspiration tips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/08—Lipoids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/058—General characteristics of the apparatus combined with other kinds of therapy with ultrasound therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A composition of matter, device and method for dissolving fat associated, with or near the skin. The composition is directed to perfluorocarbon compositions, the devices incorporate perfluorocarbons for topical application to the skin, and methods involve either subdermal injection or topical application of perfluorocarbon compositions.
PCT/US1999/029374 1999-01-12 1999-12-09 Composition, device, and method for subcutaneous fat removal WO2000041671A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23170599A 1999-01-12 1999-01-12
US09/231,705 1999-01-12

Publications (3)

Publication Number Publication Date
WO2000041671A2 WO2000041671A2 (en) 2000-07-20
WO2000041671A3 true WO2000041671A3 (en) 2000-11-23
WO2000041671A9 WO2000041671A9 (en) 2002-04-11

Family

ID=22870339

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/029374 WO2000041671A2 (en) 1999-01-12 1999-12-09 Composition, device, and method for subcutaneous fat removal

Country Status (1)

Country Link
WO (1) WO2000041671A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006255097B2 (en) 2005-06-06 2012-02-09 Georgetown University Compositions and methods for lipo modeling
US9888933B1 (en) * 2008-10-14 2018-02-13 Alfredo Ernesto Hoyos Ariza Vaser assisted high definition liposculpture
US10980925B1 (en) 2008-10-14 2021-04-20 A Hoyos Llc High definition liposculpture
FR2937554B1 (en) * 2008-10-27 2010-11-12 Yves Crassas AQUEOUS SALT SOLUTIONS FOR THE DESTRUCTION OF FAT FABRICS
USD883767S1 (en) 2018-10-10 2020-05-12 A Hoyos Llc Handle

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455373A (en) * 1994-02-28 1995-10-03 Exfluor Research Corporation Method of producing perfluorocarbon halides
US5637318A (en) * 1992-06-26 1997-06-10 Lancaster Group Ag Dermatological agent for assisting the transport of oxygen in the skin
US5679459A (en) * 1992-06-03 1997-10-21 Alliance Pharmaceutical Corp. Perfluorinated amphiphilic phosphorous compounds: liposomal compositions
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5763423A (en) * 1996-01-04 1998-06-09 Clarion Pharmaeuticals Inc. Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5679459A (en) * 1992-06-03 1997-10-21 Alliance Pharmaceutical Corp. Perfluorinated amphiphilic phosphorous compounds: liposomal compositions
US5637318A (en) * 1992-06-26 1997-06-10 Lancaster Group Ag Dermatological agent for assisting the transport of oxygen in the skin
US5455373A (en) * 1994-02-28 1995-10-03 Exfluor Research Corporation Method of producing perfluorocarbon halides
US5763423A (en) * 1996-01-04 1998-06-09 Clarion Pharmaeuticals Inc. Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine

Also Published As

Publication number Publication date
WO2000041671A2 (en) 2000-07-20
WO2000041671A9 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
WO2002028425A3 (en) Methods for treating muscle injuries
NO20020299D0 (en) Treatment and composition to achieve anti-aging skin with Corneum Protease activation
WO2006083979A3 (en) Local treatment of neurofibromas
EP1186290A3 (en) Method and device for treating scars
AU3957400A (en) Dry, mouldable drug formulation
WO2003002175A8 (en) Enhanced systemic absorption of intradermally delivered substances
AU3104301A (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
WO2001074307A3 (en) Compositions and methods for treating hair loss using oximyl- and hydroxylamino- prostaglandins
WO1999043296A3 (en) Anti-irritants in cosmetic compositions
WO2004052308A3 (en) Topical anti-infective formulations
WO2002002093A3 (en) Combination containing an antifolate and methylmalonic acid lowering agent
WO2001091774A3 (en) Method of treating chronic ulcers
EP1338270A3 (en) Use of a dihydrochalcone-rich phenolic fraction in a cosmetic composition
IL94582A0 (en) Preparation for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
WO2000041671A3 (en) Composition, device, and method for subcutaneous fat removal
CA2326528A1 (en) Cholesterol sulfate compositions for artificial skin tanning
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
WO2003007900A3 (en) Skin treatment
AU2420001A (en) Methods and compositions for the treatment of pain
EP1621207A3 (en) Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
BR0107544A (en) Bile secretion promotion composition
EP0693479A4 (en) Novel aconitine-like compound and antipyretic analgesic anti-inflammatory agent
WO2002054996A3 (en) Terazosin transdermal device and methods
WO1999047105A3 (en) Liquid antimicrobial, skin moisturizing formulation
WO2005041854A3 (en) Composition for the cosmetic treatment of age-related dermatological symptoms

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): BR CA CN IL JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): BR CA CN IL JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): BR CA CN IL JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 4/5-5/5, DRAWINGS, REPLACED BY NEW PAGES 4/5-5/5; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase